Cytokine-Associated Angioedema Syndromes Including Episodic Angioedema with Eosinophilia (Gleich's Syndrome)

Immunology and Allergy Clinics of North America

Volumn 26, Issue 4, 2006, Pages 769-781

  Banerji, Aleena ^a   Weller, Peter F ^b   Sheikh, Javed ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHYLLINE; ANTIHISTAMINIC AGENT; CALCIUM ANTAGONIST; CORTICOSTEROID; CYTOKINE; EOSINOPHIL PROTEIN X; GINKGO BILOBA EXTRACT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 5; INTERLEUKIN 6; LOOP DIURETIC AGENT; MAJOR BASIC PROTEIN; PREDNISONE; PROSTACYCLIN; RECOMBINANT ALPHA INTERFERON; RECOMBINANT INTERLEUKIN 2; SALBUTAMOL; STEROID; TERBUTALINE; VASCULOTROPIN;

ANGIONEUROTIC EDEMA; CAPILLARY LEAK SYNDROME; CLINICAL FEATURE; CYTOKINE RELEASE; DERMATITIS; ECZEMA; EOSINOPHILIA; ERYTHEMA; FACE EDEMA; FEVER; GLEICH SYNDROME; HUMAN; IMMUNOPATHOGENESIS; KIDNEY CARCINOMA; LONG TERM CARE; LOW DRUG DOSE; NODULE EOSINOPHILIA RHEUMATISM DERMATITIS SWELLING SYNDROME; NON EPIDOSODIC ANGIOEDEMA WITH EOSINOPHILIA; PATHOPHYSIOLOGY; PATIENT CARE; PRIORITY JOURNAL; PRURITUS; REVIEW; RHEUMATIC DISEASE; SKIN NODULE; SKIN SWELLING; SKIN TOXICITY; URTICARIA; WEIGHT GAIN;

ANGIONEUROTIC EDEMA; CYTOKINES; EOSINOPHILIA; HUMANS; SYNDROME;

EID: 33751028535     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2006.09.001     Document Type: Review

References (46)

1. Chikama R., Hosokawa M., Miyazawa T., et al. Nonepisodic angioedema associated with eosinophilia: report of 4 cases and review of 33 young female patients reported in Japan. Dermatology 197 (1998) 321-325
2. Garcia-Abujeta J.L., Martin-Gil D., Martin M., et al. Impaired type-1 activity and increased NK cells in Gleich's syndrome. Allergy 56 (2001) 1221-1225
3. Moqbel R., and Coughlin J.J. Differential secretion of cytokines. Sci STKE 338 (2006) pe26
4. Gleich G.J., Schroeter A.L., Marcoux J.P., et al. Episodic angioedema associated with eosinophilia. N Engl J Med 310 (1984) 1621-1626
5. Bochner B.S., Friedman B., Krishnaswami G., et al. Episodic eosinophilia-myalgia-like syndrome in a patient without L-tryptophan use: association with eosinophil activation and increased serum levels of granulocyte-macrophage colony-stimulating factor. J Allergy Clin Immunol 88 (1991) 629-636
6. Butterfield J.H., Leiferman K.M., Abrams J., et al. Elevated serum levels of interleukin-5 in patients with the syndrome of episodic angioedema and eosinophilia. Blood 79 (1992) 688-692
7. Tillie-Leblond I., Gosset P., Janin A., et al. Increased interleukin-6 production during the acute phase of the syndrome of episodic angioedema and hypereosinophilia. Clin Exp Allergy 28 (1998) 491-496
8. Lassalle P., Gosset P., Gruart V., et al. Presence of antibodies against endothelial cells in the sera of patients with episodic angioedema and hypereosinophilia. Clin Exp Immunol 82 (1990) 38-43
9. Harada M., Kumemura H., Yanagimoto C., et al. Vascular endothelial growth factor is involved in angioedema associated with eosinophilia. Kurume Med J 52 (2005) 89-91
10. Putterman C., Barak V., Caraco Y., et al. Episodic angioedema with eosinophilia: a case associated with T cell activation and cytokine production. Ann Allergy 70 (1993) 243-248
11. Ohmoto K., and Yamamoto S. Angioedema after interferon therapy for chronic hepatitis C. Am J Gastroenterol 96 (2001) 1311-1312
12. Morgan S.J., Prince H.M., Westerman D.A., et al. Clonal T-helper lymphocytes and elevated IL-5 levels in episodic angioedema and eosinophilia (Gleich's syndrome). Leuk Lymphoma 44 (2003) 1623-1625
13. Lorraine J.K. Successful pregnancy in a woman with cyclic angioedema and eosinophilia. Ann Allergy Asthma Immunol 77 (1996) 497-499
14. Katzen D.R., Leiferman K.M., Weller P.F., et al. Hypereosinophilia and recurrent angioneurotic edema in a 2 1/2-year-old girl. Am J Dis Child 140 (1986) 62-64
15. Klion A.D., Bochner B.S., Gleich G.J., et al. The Hypereosinophilic Syndromes Working G: approaches to the treatment of hypereosinophilic syndromes: a workshop summary report. J Allergy Clin Immunol 117 (2006) 1292-1302
16. Nakashima K., Sakurada T., Imayama S., et al. A case of episodic angioedema associated with blood eosinophilia: upregulated C5a receptor expression on eosinophils. Allergy 53 (1998) 320-323
17. Songsiridej V., Peters M.S., Dor P.J., et al. Facial edema and eosinophilia. Evidence for eosinophil degranulation. Ann Intern Med 103 (1985) 503-506
18. Emonet S., Kaya G., and Hauser C. [Gleich's syndrome.]. Ann Dermatol Venereol 127 (2000) 616-618 [in French]
19. Schiavino D., Gentiloni N., Murzilli F., et al. Episodic angioedema with eosinophilia (Gleich syndrome). Allergol Immunopathol (Madr) 18 (1990) 233-236
20. Ray A., and Sehgal P.B. Cytokines and their receptors: molecular mechanism of interleukin-6 gene repression by glucocorticoids. J Am Soc Nephrol 2 (1992) S214-S221
21. Shimasaki A.K. [Five cases of nonepisodic angioedema with eosinophilia.]. Rinsho Ketsueki 42 (2001) 639-643 [in Japanese]
22. Mizukawa Y., and Shiohara T. The cytokine profile in a transient variant of angioedema with eosinophilia. Br J Dermatol 144 (2001) 169-174
23. Okamoto H., and Kamatani N. Plasma concentration of TARC/CCL17 is elevated in nonepisodic angioedema associated with eosinophilia. Allergy 60 (2005) 1091-1092
24. Butterfield J.H., Leiferman K.M., and Gleich G.J. Nodules, eosinophilia, rheumatism, dermatitis and swelling (NERDS): a novel eosinophilic disorder. Clin Exp Allergy 23 (1993) 571-580
25. Zenarola P., Melillo L., Bisceglia M., et al. NERDS syndrome: an additional case report. Dermatology 191 (1995) 133-138
26. Clarkson B., Thompson D., Horwith M., et al. Cyclical edema and shock due to increased capillary permeability. Am J Med 29 (1960) 193-216
27. Airaghi L., Montori D., Santambrogio L., et al. Chronic systemic capillary leak syndrome. Report of a case and review of the literature. J Intern Med 247 (2000) 731-735
28. Fischer R., Ostendorf B., Richter J., et al. [Hypovolemic shock associated with generalized edema: paroxysmal non-hereditary angioedema (Clarkson syndrome).]. Dtsch Med Wochenschr 125 (2000) 427-428 [in German]
29. Tahirkheli N.K., and Greipp P.R. Treatment of the systemic capillary leak syndrome with terbutaline and theophylline. A case series. Ann Intern Med 130 (1999) 905-909
30. Cau C. [Syndrome of increased idiopathic capillary permeability (Clarkson's syndrome).]. Minerva Med 90 (1999) 391-396 [in Italian]
31. Chihara R., Nakamoto H., Arima H., et al. Systemic capillary leak syndrome. Intern Med 41 (2002) 953-956
32. Amoura Z., Papo T., Ninet J., et al. Systemic capillary leak syndrome: report on 13 patients with special focus on course and treatment. Am J Med 103 (1997) 514-519
33. Hiraoka E., Matsushima Y., Inomoto-Naribayashi Y., et al. Systemic capillary leak syndrome associated with multiple myeloma of IgG kappa type. Intern Med 34 (1995) 1220-1224
34. Zhang W., Ewan P.W., and Lachmann P.J. The paraproteins in systemic capillary leak syndrome. Clin Exp Immunol 93 (1993) 424-429
35. Vella F.S., Panella E., Masciale N., et al. [Clarkson syndrome: a rare clinical condition characterized by generalized edema associated to monoclonal gammopathy.]. Recenti Prog Med 96 (2005) 488-491 [in Italian]
36. Garces S., Araujo F., Rego F., et al. Capillary leakage syndrome: a case report and a review. Allerg Immunol (Paris) 34 (2002) 361-364
37. Nurnberger W., Heying R., Burdach S., et al. C1 esterase inhibitor concentrate for capillary leakage syndrome following bone marrow transplantation. Ann Hematol 75 (1997) 95-101
38. Fronhoffs S., Luyken J., Steuer K., et al. The effect of C1-esterase inhibitor in definite and suspected streptococcal toxic shock syndrome. Report of seven patients. Intensive Care Med 26 (2000) 1566-1570
39. Cicardi M., Berti E., Caputo V., et al. Idiopathic capillary leak syndrome: evidence of CD8-positive lymphocytes surrounding damaged endothelial cells. J Allergy Clin Immunol 99 (1997) 417-419
40. Hoffmann U., Fontana A., Steurer J., et al. Idiopathic oedema with increased cytokine production: a pathogenetic link?. J Intern Med 244 (1998) 179-182
41. Cicardi M., Gardinali M., Bisiani G., et al. The systemic capillary leak syndrome: appearance of interleukin-2-receptor-positive cells during attacks. Ann Intern Med 113 (1990) 475-477
42. Rondeau E., Sraer J., Bens M., et al. Production of 5-lipoxygenase pathway metabolites by peripheral leucocytes in capillary leak syndrome (Clarkson disease). Eur J Clin Invest 17 (1987) 53-57
43. Abraham D., and McGrath K.G. Hypersensitivity to aldesleukin (interleukin-2 and proleukin) presenting as facial angioedema and erythema. Allergy Asthma Proc 24 (2003) 291-294
44. Sundin D.J., and Wolin M.J. Toxicity management in patients receiving low-dose aldesleukin therapy. Ann Pharmacother 32 (1998) 1344-1352
45. Junghans R.P., Manning W., Safar M., et al. Biventricular cardiac thrombosis during interleukin-2 infusion. N Engl J Med 344 (2001) 859-860
46. Guillot B., Blazquez L., Bessis D., et al. A prospective study of cutaneous adverse events induced by low-dose alpha-interferon treatment for malignant melanoma. Dermatology 208 (2004) 49-54